Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Intellikine, Somaxon, and More 12/22/11 San Diego
In a Detour From Device Strategy, Zogenix Edges Closer to New Drug Application 10/27/11 San Diego
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News 08/18/11 San Diego
San Diego’s Cadence Gets a Generic Headache, aTyr Pharma Seeks Structure for Diverse Funding, CareFusion Plans Global Expansion, & More San Diego Life Sciences News 07/07/11 San Diego
Cadence Faces Competition from Generic Pain Reliever, Less Than a Year After FDA Approval 06/30/11 San Diego
Cadence Tacks on $86.2M 11/11/10 San Diego
Biogen Idec Closing San Diego Center, Cadence Wins FDA Approval, Adventrx Files New Drug Application, & More San Diego Life Sciences News 11/04/10 San Diego
Cadence Wins FDA Green Light for Hospital-Based Pain Reliever 11/02/10 San Diego
Avalon Raising New Fund, Althea Technologies Gets Altus Assets, Trancon Pharmaceuticals Nabs Financing, & More San Diego Life Sciences News 05/06/10 San Diego
Cadence Re-Files FDA Application 05/05/10 San Diego
CareFusion Hits Acquisition Trail, Cadence Pharmaceuticals Enlists Manufacturing Expertise, Medsphere Systems Sees Explosion in Bookings, & More San Diego Life Sciences News 04/08/10 San Diego
Cadence’s Manufacturing Woes Detailed; Black Eye for Baxter? 02/25/10 San Diego
Another Setback for Cadence, Stimulus Funds Help Fuel Life Sciences Jobs, Tioga Gets More Funding for Drug Trial & More San Diego Life Sciences News 02/18/10 San Diego
Cadence Pharmaceuticals’ Pain Reliever Handed Second Regulatory Setback 02/11/10 San Diego
Isis Extends Timeline on Cholesterol-Lowering Drug, FDA Delays Review of Cadence Pain Reliever, Fate Therapeutics Raises $30 Million, & More San Diego Life Sciences News 11/19/09 San Diego
Cadence Hit By FDA Delay 11/13/09 San Diego
Biotechs Go Back to the Future by Re-Innovating Old Drugs 08/26/09 San Diego
Sciele Pharma Cancels Victory Pharma Buyout, Life Science Startups Raise Capital, Sorrento Therapeutics Engineers Reverse Merger, & More San Diego Life Sciences News 07/16/09 San Diego
Canceled Buyout Snatches Victory From Victory Pharma’s Investors 07/15/09 San Diego
Intellikine Raises $28.5M, Cadence Awaits FDA Action, Somaxon Seeks FDA Approval Again for Insomnia Drug, & More San Diego Life Sciences News 07/09/09 San Diego
Cadence, Aiming to Reduce Narcotics Use in Hospitals, Gears Up to Market IV Pain Reliever 07/07/09 San Diego
Cadence Applies for FDA Approval 05/14/09 San Diego
Early Histogen Study Offers Hope for Retreating Hairlines, Cadence Pharmaceuticals and Vertex Raise Lots of Cash, Unmanned Predator Begins New Air Patrol, & More San Diego BizTech News 02/23/09 San Diego
Cadence Raises $86.6M in Private Stock Offering 02/17/09 San Diego
Cadence Turns Attention to Marketplace, as IV Pain Reliever Reaches Goals in Clinical Trials 12/18/08 San Diego
Cadence Shares Boom as IV Pain Reliever Reaches Goal in Study 12/17/08 San Diego
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.